Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

35 results
Display

Rosuvastatin-induced Generalized Drug Eruption

Choi MW, Lee JH, Noh TK, Han TY

  • KMID: 2437066
  • Korean J Dermatol.
  • 2018 Dec;56(10):651-653.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9)

Sohn TS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9)

Hwang YC

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans

Bae SH, Park WS, Han S, Park GJ, Lee J, Hong T, Jeon S, Yim DS

It was recently reported that the C(max) and AUC of rosuvastatin increases when it is coadministered with telmisartan and cyclosporine. Rosuvastatin is known to be a substrate of OATP1B1, OATP1B3,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus

Hwang YC, Jun JE, Jeong IK, Ahn KJ, Chung HY

BACKGROUND: The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Blood pressure lowering effect of statin drugs with an application to rosuvastatin

Heo YA, Son M, Park K

Hyperlipidemia and hypertension are among the major risk factors for cardiovascular disease (CVD) and they often co-exist within a single patient. Recently, many studies published results regarding the potential role...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Economic Evaluation of Rosuvastatin and Atorvastatin for the Treatment of Dyslipidemia from a Korean Health System Perspective

Suh S, Jung CH, Hong SJ, Kim JS, Song BJ, Sohn HS, Choi SH

OBJECTIVE: This study aims to analyze cost-effectiveness of two most-commonly used statins from the perspective of the Korean national health system. METHODS: The scope of the analysis included rosuvastatin (5 mg,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes

Han E, Kim G, Lee JY, Lee YH, Kim BS, Lee BW, Cha BS, Kang ES

BACKGROUND: Although the beneficial effects of statin treatment in dyslipidemia and atherosclerosis have been well studied, there is limited information regarding the renal effects of statins in diabetic nephropathy. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects

Hwang I, Park SI, Lee S, Lee B, Yu KS, Jeon JY, Kim MG

This study aimed to compare the pharmacokinetics of fixed-dose combination (FDC) tablet of rosuvastatin 20 mg/ezetimibe 10 mg with that of concurrent administration of individual rosuvastatin 20 mg tablet and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antioxidative Activity after Rosuvastatin Treatment in Patients with Stable Ischemic Heart Disease and Decreased High Density Lipoprotein Cholesterol

Park DS, Yun KH, Park HY, Rhee SJ, Kim NH, Oh SK, Jeong JW

BACKGROUND AND OBJECTIVES: The clinical significance of statin-induced high-density lipoprotein cholesterol (HDL-C) changes is not well known. We investigated whether rosuvastatin-induced HDL-C changes can influence the anti-oxidative action of high-density...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Statin-Induced Interstitial Pneumonitis due to Rosuvastatin

Kim SY, Kim SJ, Yoon D, Hong SW, Park S, Ock CY

Statins lower the hyperlipidemia and reduce the incidence of cardiovascular events and related mortality. A 60-year-old man who was diagnosed with a transient ischemic attack was started on acetyl-L-carnitine, cilostazol,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Regression of asymptomatic intracranial arterial stenosis by aggressive medical management with a lipid-lowering agent

Kim BS, Lim JS, Jeong JU, Mun JH, Kim SH

OBJECTIVE: The incidence rate of stroke as a result of intracranial arterial stenosis (ICAS) is higher in Asian countries than in the West. We aimed to analyze the regression, lack...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Anti-Inflammatory Effects of Statin in 5/6 Nephrectomized Rats

Park MY, Choi SJ, Kim JK, Hwang SD

  • KMID: 2264156
  • Korean J Med.
  • 2011 Dec;81(6):740-750.
BACKGROUND/AIMS: In a previous study, statin therapy reduced proteinuria and ameliorated the progression of chronic kidney disease. However, in patients with chronic renal failure (CRF), the beneficial effect of statin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rosuvastatin Does Not Affect Fasting Glucose, Insulin Resistance, or Adiponectin in Patients with Mild to Moderate Hypertension

Kim W, Hong MJ, Woo JS, Kang WY, Hwang SH, Kim W

The effects of statins on insulin resistance and new-onset diabetes are unclear. The purpose of this study was to evaluate the effects of rosuvastatin on insulin resistance and adiponectin in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus

Kong SH, Koo BK, Moon MK

BACKGROUND: There has been evidences of ethnic differences in the low density lipoprotein cholesterol (LDL-C) lowering effect of statin. We aimed to evaluate the efficacy of moderate-intensity statins in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of High-Dose Statin Pretreatment in Patients with Stable Angina during Off-Pump Coronary Artery Bypass

Youn YN, Park SY, Hwang Y, Joo HC, Yoo KJ

  • KMID: 2288823
  • Korean J Thorac Cardiovasc Surg.
  • 2011 Jun;44(3):208-214.
BACKGROUND: Periprocedural treatment with high-dose statins is known to have cardioprotective and pleiotropic effects, such as anti-thrombotic and anti-inflammatory actions. We aimed to assess the efficacy of high-dose rosuvastatin loading...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Rosuvastatin on Bovine Pericardial Aortic Tissue Valve Calcification in a Rat Subdermal Implantation Model

Lee SH, Kim DH, Youn YN, Lee S, Joo HC, Chang BC, Yoo KJ

BACKGROUND AND OBJECTIVES: There are pathophysiologic similarities between calcification and atherosclerosis because both are the product of an active inflammatory process. The aim of this study was to examine the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect and Safety of Rosuvastatin in Acute Ischemic Stroke

Heo JH, Song D, Nam HS, Kim EY, Kim YD, Lee KY, Lee KJ, Yoo J, Kim YN, Lee BC, Yoon BW, Kim JS, EUREKA Investigators

BACKGROUND AND PURPOSE: The benefit of statins in acute stroke remains uncertain. Statins may prevent stroke recurrence during the acute stage of stroke via pleiotropic effects. However, statins may increase...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Efficacy and Safety after Administering High Potency Statin to High Risk Patients: Rosuvastatin 10 mg versus Atorvastatin 20 mg

Yun KH, Park HY, Choi JH, Song MJ, Park EM, Kim YK, Rhee SJ, Lee EM, Lee J, Yoo NJ, Kim NH, Oh SK, Jeong JW

BACKGROUND AND OBJECTIVES: Although the rate of prescribing hydroxylmethyglutaryl-CoA reductase inhibitors (statin) has recently increased, there is a large treatment gap between the guidelines and actual clinical practice. We studied...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy

Yun KH, Lim JH, Hwang KB, Woo SH, Jeong JW, Kim YC, Joe DY, Ko JS, Rhee SJ, Lee EM, Oh SK

BACKGROUND AND OBJECTIVES: Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality. This observational, non-randomized study evaluated the effect of rosuvastatin loading before percutaneous coronary intervention (PCI) on the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr